STRYKER CORP - 8-K Filing
Stryker reports Q3 2026 net sales of $6.5 billion, up 7.7% YoY, and updates full-year organic growth guidance to 6.5%-7.0%.
Tickers: $SYK
Read the full article at SEC EDGAR
Part of the story Novartis Raises 2026 Core Operating Income Guidance Following Sales Growth (7 articles)